Codagenix, Inc.

A clinical stage, synthetic-biology based platform for constructing live-attenuated vaccine strains the are antigenically identical to the target

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Farmingdale, NY, US
  • Currency USD
  • Founded August 2012
  • Employees 37
  • Incorporation Type C-corp
  • Website codagenix.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free